title: ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).
authors.affiliation: European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
authors.forename: F
authors.initials: F
authors.lastname: Cardoso
authors.affiliation: European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Costa
authors.affiliation: Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.
authors.forename: L
authors.initials: L
authors.lastname: Norton
authors.affiliation: Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
authors.forename: E
authors.initials: E
authors.lastname: Senkus
authors.affiliation: Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.
authors.forename: M
authors.initials: M
authors.lastname: Aapro
authors.affiliation: Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France.
authors.forename: F
authors.initials: F
authors.lastname: André
authors.affiliation: Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
authors.forename: C H
authors.initials: CH
authors.lastname: Barrios
authors.affiliation: Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Bergh
authors.affiliation: Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Biganzoli
authors.affiliation: Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA.
authors.forename: K L
authors.initials: KL
authors.lastname: Blackwell
authors.affiliation: Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal.
authors.forename: M J
authors.initials: MJ
authors.lastname: Cardoso
authors.affiliation: University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia.
authors.forename: T
authors.initials: T
authors.lastname: Cufer
authors.affiliation: NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
authors.forename: N
authors.initials: N
authors.lastname: El Saghir
authors.affiliation: Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
authors.forename: L
authors.initials: L
authors.lastname: Fallowfield
authors.affiliation: Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
authors.forename: D
authors.initials: D
authors.lastname: Fenech
authors.affiliation: Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
authors.forename: P
authors.initials: P
authors.lastname: Francis
authors.affiliation: BC Cancer Agency, Vancouver, Canada.
authors.forename: K
authors.initials: K
authors.lastname: Gelmon
authors.affiliation: Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA.
authors.forename: S H
authors.initials: SH
authors.lastname: Giordano
authors.affiliation: APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Gligorov
authors.affiliation: Program of Breast Health, European Institute of Oncology, Milan, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Goldhirsch
authors.affiliation: Brustzentrum der Universität München, Munich, DE, USA.
authors.forename: N
authors.initials: N
authors.lastname: Harbeck
authors.affiliation: Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia.
authors.forename: N
authors.initials: N
authors.lastname: Houssami
authors.affiliation: Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA.
authors.forename: C
authors.initials: C
authors.lastname: Hudis
authors.affiliation: Sheba Medical Center, Tel Hashomer, Israel.
authors.forename: B
authors.initials: B
authors.lastname: Kaufman
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
authors.forename: I
authors.initials: I
authors.lastname: Krop
authors.affiliation: Europa Donna Cyprus, Nicosa, Cyprus.
authors.forename: S
authors.initials: S
authors.lastname: Kyriakides
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
authors.forename: U N
authors.initials: UN
authors.lastname: Lin
authors.affiliation: Advanced BC.org, New York, USA.
authors.forename: M
authors.initials: M
authors.lastname: Mayer
authors.affiliation: University of Michigan Medical School and School of Public Health, Ann Arbor, USA.
authors.forename: S D
authors.initials: SD
authors.lastname: Merjaver
authors.affiliation: Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden.
authors.forename: E B
authors.initials: EB
authors.lastname: Nordström
authors.affiliation: Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
authors.forename: O
authors.initials: O
authors.lastname: Pagani
authors.affiliation: Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.
authors.forename: A
authors.initials: A
authors.lastname: Partridge
authors.affiliation: Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
authors.forename: F
authors.initials: F
authors.lastname: Penault-Llorca
authors.affiliation: Department of Medicine, Institut Jules Bordet, Brussels, Belgium.
authors.forename: M J
authors.initials: MJ
authors.lastname: Piccart
authors.affiliation: Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
authors.forename: H
authors.initials: H
authors.lastname: Rugo
authors.affiliation: Indiana University Medical CTR, Indianapolis, USA.
authors.forename: G
authors.initials: G
authors.lastname: Sledge
authors.affiliation: Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Thomssen
authors.affiliation: Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
authors.forename: L
authors.initials: L
authors.lastname: Van't Veer
authors.affiliation: Sandton Oncology Centre, Johannesburg, South Africa.
authors.forename: D
authors.initials: D
authors.lastname: Vorobiof
authors.affiliation: Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland.
authors.forename: C
authors.initials: C
authors.lastname: Vrieling
authors.affiliation: Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK.
authors.forename: N
authors.initials: N
authors.lastname: West
authors.affiliation: Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
authors.forename: B
authors.initials: B
authors.lastname: Xu
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
authors.forename: E
authors.initials: E
authors.lastname: Winer
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D058922:Inflammatory Breast Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D010166:Palliative Care / Q000379:methods; D011788:Quality of Life; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; C508053:ERBB2 protein, human